The NMDA receptor antagonist MK-801 prevents imipramine-induced supersensitivity to quinpirole

European Journal of Pharmacology

Volumn 224, Issue 2-3, 1992, Pages 199-202

  D'Aquila, Paolo S ^a   Sias, Alessandro ^a   Gessa, Gian Luigi ^a   Serra, Gino ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Dopamine receptors; Imipramine (chronic); NMDA receptors; Supersensitivity

Indexed keywords

DIZOCILPINE; IMIPRAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SUPERSENSITIVITY;

ANIMAL; DIZOCILPINE MALEATE; DOPAMINE AGENTS; DRUG INTERACTIONS; ERGOLINES; IMIPRAMINE; MALE; MOTOR ACTIVITY; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SUPPORT, NON-U.S. GOV'T;

EID: 0026526398     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(92)90805-E     Document Type: Article

References (16)

1. In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-D-aspartate evoked striatal dopamine release and effects of antagonists
2. Effect of chronic treatment with dizocilpine (MK-801) on the behavioural response to dopamine receptor agonists in the rat
3. Selective adenylate cycluse increase in the limbic area of long-term imipramine-treated rats
4. NMDA receptors and in vivo dopamine release in the nucleus accumbens und caudatus
5. Effect of MK-801 on endogenous dopamine release in vivo
6. The effect of phencyclidin and DL-2-amino-5-phosphonovaleric acid on N-methyl-D-aspartic acid induced changes in extracellular concentration of dopamine and DOPAC in the rat neowtriatum
7. Physiological and pathophysiological roles of excitatory aminoacids during central nervous system development
8. Chronic desipramine enhances amphetamine-induced increases in interstitial concentrations of dopamine in the nucleus accumbens
9. Electrophysiological evidence that intrastriatally administered N-methyl-D-aspartate augments striatal dopamine tone in the rat
10. Nucleus accumbens NMDA antagonist decreases locomotor activity produced by cocaine, heroin, or accumbens dopamine, but not caffeine
11. Repeated treatment with imipramine potentiates cocaine-induced dopamine release and motor stimulation
12. Chronic treatment with antidepressants prevents the inhibitory effect of small doses of apomorphine on dopamine synthesis and motor activity
13. 1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants
14. 2-, mediated changes in striatal and accumbens neurotensin systems
15. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801
16. Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effect but blocks sensitization to amphetamine